Cardiovascular Diseases

Qualified Health Claim for High Oleic Acid Oils

The U.S. Food and Drug Administration (FDA) responded to a petition for a new qualified health claim for edible oils containing high levels of oleic acid, a monounsaturated fat that’s been shown to have cardiovascular benefits when it replaces heart-damaging saturated fat. Manufacturers of these oils can choose to include a qualified health claim on their label stating that “supportive but not conclusive scientific evidence suggests that daily consumption of about 1½ tablespoons (20 grams) of oils containing high levels of oleic acid, may reduce the risk of coronary heart disease.” The claim will also need to make it clear that to achieve this benefit, these oils “should replace fats and oils higher in saturated fat and not increase the total number of calories you eat in a day.” Edible oils must contain at least 70 percent oleic acid to meet the criteria for this qualified health claim. Specific edible oils include: high oleic sunflower oil, high oleic safflower oil, high oleic canola oil, olive oil and high oleic algal oil. Some high oleic oils will not degrade when heated to high temperatures, which makes them ideal to use for baking or frying. The science behind the new qualified health claim for oleic acid, while not conclusive, is promising. Importantly, there is no study found that eating oleic acid-containing oils had beneficial heart effects unless they replaced other types of fats and oils higher in saturated fats in the diet. Source: https://www.fda.gov/

hyangiu

Recent Posts

Mindfulness-Based Stress Reduction on Par with Escitalopram for Anxiety Disorders

Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…

4 days ago

Key Messages of 2024 ESC Guidelines for High BP

The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…

1 month ago

CRP, LDL Cholesterol, and Lipoprotein(a) Levels Predictive of CVD

A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…

1 month ago

No Benefit to Stop Beta-Blockers After MI

A French multicenter, open label, randomized, noninferiority trial suggested that interruption of long-term beta-blocker treatment…

2 months ago

Plant vs Animal Fat on Mortality

A US prospective cohort study demonstrated that replacement of animal fat with an equivalent amount…

2 months ago

UK T2D Remission Program Findings

An ongoing UK national prospective program shows remission of type 2 diabetes (T2D) outside of…

2 months ago

This website uses cookies.